Analyst Coverage
Firm | Analyst | Contact Information |
---|---|---|
Bank of America/Merrill Lynch
|
Sachin Jain | |
Barclays
|
Emily Field | |
BMO
|
Etzer Darout, PhD | |
BNP Paribas Exane
|
Victor Floc'h | |
BTIG
|
Kaveri Pohlman, PhD | |
Carnegie Bank
|
Jesper Ilsøe | |
Citi
|
Peter Verdult | |
Cowen
|
Yaron Werber, M.D. | |
Danske Markets Equities
|
Thomas Bowers | |
Deutsche Bank AG
|
Emmanuel Papadakis, PhD CFA | |
DNB
|
Rune Majlund Dahl | |
Goldman Sachs International
|
Rajan Sharma | |
Guggenheim Securities, LLC
|
Michael Schmidt, Ph.D. | |
Handelsbanken
|
Suzanna Queckbörner, PhD | |
H.C. Wainwright & Co.
|
Raghuram Selvaraju, Ph.D. | |
HSBC Bank Plc
|
Yifeng Liu | |
Jefferies International Ltd.
|
Peter Welford | |
J.P. Morgan
|
James Gordon | |
Jyske Bank
|
Henrik Hallengreen Laustsen | |
Kempen & Co
|
Suzanne van Voorthuizen | |
LeeRink Partners
|
Jonathan Chang | |
Morgan Stanley & Co. LLC
|
Vikram Purohit | |
Nordea
|
Michael Novod | |
RBC Capital Markets, LLC
|
Alistair Campbell | |
Societe Generale
|
Justin Smith | |
Sydbank
|
Søren Løntoft Hansen | |
Truist Securities
|
Asthika Goonewardene | |
UBS
|
Dr. Xian Deng, CFA | |
William Blair
|
Matt Phipps, Ph.D. |
Genmab A/S is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding Genmab A/S's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Genmab A/S or its management. Genmab A/S does not by its reference or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.